AEYE is up +392.76% since Feb ’24 pick Unlock All Top Buy Picks

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 1.844 1 day ( 0 % )
Last Price $3.00 6.76 %
High/ Low $2.82 - $3.30 23.95%
Chg 7 Days 11.94 % $2.68 $3.00
Chg 30 Days -12.54 % $3.43 $3.00
Chg 12 mos 46.34 % $2.05 $3.00
Trend - 3 mos 61.35 % Width: 54.22 %
Trend - 12 mos 17.28 % Width: 262.63 %
Pred. range - 3 mos $4.25 - $6.56 41.70 % - 118.53 %
Pred. range - 12 mos $1.16 - $4.20 -61.36 % - 40.12 %
Short MA avg 3 mos Buy May 17, 2024 - 3 days
Long MA avg 3 mos Buy May 20, 2024 - 2 days
Short/Long MA avg 3 mos Sell May 15, 2024 - 5 days
Short MA avg 12 mos Buy May 20, 2024 - 2 days
Long MA avg 12 mos Sell Jan 31, 2024 - 78 days
Short/Long MA avg 12 mos Buy Jan 29, 2024 - 80 days
Pivot Short Sell Apr 02, 2024 - 36 days
Bollinger Buy Nov 09, 2023 - 133 days
MACD Sell No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!

About Rezolute, Inc.

Rezolute. Rezolute, Inc., a clinical stage biopharmaceutical company, develops transformative therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultra-rare pediatric genetic disorder. It is also developing RZ402, a selective and potent plasma kallikrei... RZLT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT